Andrey Ivanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrey Ivanov has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Elisaveta Levunlieva
National Heart Hospital, Sofia, Bulgaria
2 shared publications - Emil Manov
Department of Internal Diseases “Prof. St. Kirkovich”, Medical University of Sofia, 1431 Sofia, Bulgaria
2 shared publications - Nikolay Runev
Department of Internal Diseases “Prof. St. Kirkovich”, Medical University of Sofia, 1431 Sofia, Bulgaria
2 shared publications - Stefan Naydenov
Department of Internal Diseases “Prof. St. Kirkovich”, Medical University of Sofia, 1431 Sofia, Bulgaria
2 shared publications
Latest Publications
- 2 April 2026
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 32 (2) , 6779-6791
LEFT VENTRICULAR HYPERTROPHY: MECHANISM OF DEVELOPMENT
Left ventricular hypertrophy (LVH) is an enlargement of the left ventricle caused by chronically increased hemodynamic load, such as arterial hypertension or aortic stenosis. In the initial stages, LVH has a protective nature, but later it can lead to heart failure and arrhythmias. The biochemical mechanisms of hypertrophy involve complex molecular pathways regulating cell proliferation and protein synthesis. These pathways interact through cell surface receptors, transcription factors, and enzymes, leading to structural and functional changes in cardiomyocytes. Changes in the extracellular matrix, inflammatory processes, and oxidative stress play an important role in the transition of hypertrophy from adaptive to pathological stage. Various hormones, vasoactive substances, growth factors, and cytokines are involved in myocardial hypertrophy. Despite significant knowledge concerning signaling pathways related to receptor stimulation, little is still known about the mechanochemical systems that transduce physical signals into cellular responses.
- 2 April 2026
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 32 (2) , 6779-6791
LEFT VENTRICULAR HYPERTROPHY: MECHANISM OF DEVELOPMENT
Left ventricular hypertrophy (LVH) is an enlargement of the left ventricle caused by chronically increased hemodynamic load, such as arterial hypertension or aortic stenosis. In the initial stages, LVH has a protective nature, but later it can lead to heart failure and arrhythmias. The biochemical mechanisms of hypertrophy involve complex molecular pathways regulating cell proliferation and protein synthesis. These pathways interact through cell surface receptors, transcription factors, and enzymes, leading to structural and functional changes in cardiomyocytes. Changes in the extracellular matrix, inflammatory processes, and oxidative stress play an important role in the transition of hypertrophy from adaptive to pathological stage. Various hormones, vasoactive substances, growth factors, and cytokines are involved in myocardial hypertrophy. Despite significant knowledge concerning signaling pathways related to receptor stimulation, little is still known about the mechanochemical systems that transduce physical signals into cellular responses.
- 26 January 2026
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 32 (1) , 6708-6718
ARTERIAL HYPERTENSION: LEFT VENTRICULAR GEOMETRY AND DIASTOLIC DYSFUNCTION
Echocardiography is an established method for assessing left ventricular structure and function in patients with arterial hypertension (AH). Purpose. The study aims to investigate left ventricular geometry and diastolic dysfunction in patients with arterial hypertension and to assess gender-related differences in the established data. Material/methods. A total of 278 individuals were studied, including 30 healthy controls (16 women and 14 men) and 248 patients with arterial hypertension (139 women and 109 men). The echocardiographic examination included M-Mode and B-Mode echocardiography, pulsed-wave spectral Doppler, and pulsed-wave tissue Doppler imaging. Results. Using the criteria of left ventricular mass index (LVMI) > 115 g/m2 in men and LVMI > 95 g/m2 in women for defining left ventricular hypertrophy (LVH), we found LVH in 147 of the hypertensive patients (59.27%). In our patients, LVH was more common in women. LVH was found in 97 women (69.78% of the women with AH) and 50 men (45.87% of the men with AH). One hundred and six (106) patients (42.74%) had no diastolic dysfunction. Grade 1 diastolic dysfunction was found in 95 patients (38.31%), grade 2 in 43 patients (17.34%), and grade 3 in 4 patients (1.61%). Conclusion. In the studied patients with arterial hypertension, a number of echocardiographic indices were found which differed significantly from those in the individuals from the control group. Regular echocardiographic assessment is essential for guiding therapy and reducing the risk in these patients.
- 26 January 2026
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 32 (1) , 6708-6718
ARTERIAL HYPERTENSION: LEFT VENTRICULAR GEOMETRY AND DIASTOLIC DYSFUNCTION
Echocardiography is an established method for assessing left ventricular structure and function in patients with arterial hypertension (AH). Purpose. The study aims to investigate left ventricular geometry and diastolic dysfunction in patients with arterial hypertension and to assess gender-related differences in the established data. Material/methods. A total of 278 individuals were studied, including 30 healthy controls (16 women and 14 men) and 248 patients with arterial hypertension (139 women and 109 men). The echocardiographic examination included M-Mode and B-Mode echocardiography, pulsed-wave spectral Doppler, and pulsed-wave tissue Doppler imaging. Results. Using the criteria of left ventricular mass index (LVMI) > 115 g/m2 in men and LVMI > 95 g/m2 in women for defining left ventricular hypertrophy (LVH), we found LVH in 147 of the hypertensive patients (59.27%). In our patients, LVH was more common in women. LVH was found in 97 women (69.78% of the women with AH) and 50 men (45.87% of the men with AH). One hundred and six (106) patients (42.74%) had no diastolic dysfunction. Grade 1 diastolic dysfunction was found in 95 patients (38.31%), grade 2 in 43 patients (17.34%), and grade 3 in 4 patients (1.61%). Conclusion. In the studied patients with arterial hypertension, a number of echocardiographic indices were found which differed significantly from those in the individuals from the control group. Regular echocardiographic assessment is essential for guiding therapy and reducing the risk in these patients.
- Open Access
- 31 December 2025
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 31 (4) , 7-29
Mechanism and diagnosis of left ventricular diastolic dysfunction
Diastolic dysfunction is a condition in which ventricular fi lling is impaired, regardless of the presence of symptoms and irrespective of whether the ejection fraction is normal or reduced. Left ventricular diastolic dysfunction results from complex and interconnected biochemical and cellular mechanisms. Among them, impaired myocardial relaxation due to calcium dysregulation, altered titin phosphorylation affecting the passive elasticity of the myocardium, and extracellular matrix remodeling with the development of fi brosis mediated by signalling pathways such as TGF-β/SMAD and MAPK play a leading role. Additional contributing factors include oxidative stress and mitochondrial dysfunction, chronic infl ammation and activation of cytokine cascades, metabolic disturbances such as diabetes and obesity, as well as protein dysfunction related to endoplasmic reticulum stress and impaired proteolysis. All these processes in complex lead to impaired diastolic fi lling of the left ventricle, i.e., diastolic dysfunction. Due to its broad availability and proven clinical value, echocardiography is the primary method for diagnosing diastolic dysfunction. Invasive and other imaging modalities offer complementary information in complex or borderline cases, or when echocardiographic evaluation is diffi cult or impossible.
- 31 December 2025
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 31 (4) , 7-29
Open AccessMechanism and diagnosis of left ventricular diastolic dysfunction
Diastolic dysfunction is a condition in which ventricular fi lling is impaired, regardless of the presence of symptoms and irrespective of whether the ejection fraction is normal or reduced. Left ventricular diastolic dysfunction results from complex and interconnected biochemical and cellular mechanisms. Among them, impaired myocardial relaxation due to calcium dysregulation, altered titin phosphorylation affecting the passive elasticity of the myocardium, and extracellular matrix remodeling with the development of fi brosis mediated by signalling pathways such as TGF-β/SMAD and MAPK play a leading role. Additional contributing factors include oxidative stress and mitochondrial dysfunction, chronic infl ammation and activation of cytokine cascades, metabolic disturbances such as diabetes and obesity, as well as protein dysfunction related to endoplasmic reticulum stress and impaired proteolysis. All these processes in complex lead to impaired diastolic fi lling of the left ventricle, i.e., diastolic dysfunction. Due to its broad availability and proven clinical value, echocardiography is the primary method for diagnosing diastolic dysfunction. Invasive and other imaging modalities offer complementary information in complex or borderline cases, or when echocardiographic evaluation is diffi cult or impossible.